ICA Group Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

ICA Group Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$578	Hold	25	–	–	﹤0.01%	752
2024 Q1	$602	Hold	25	–	–	﹤0.01%	1282
2023 Q4	$575	Buy	+25	New	+$502	﹤0.01%	1277
2023 Q3	–	Sell	-25	Closed	-$584	–	675
2023 Q2	$584	Sell	25 -25	-50%	-$600	﹤0.01%	1241
2023 Q1	$1.16K	Hold	50	–	–	﹤0.01%	1139
2022 Q4	$1.35K	Buy	+50	New	+$1.34K	﹤0.01%	1153

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ICA Group Wealth Management's IDNA Position: Q2 2024 in Review

ICA Group Wealth Management held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q2 2024 at 25 shares worth $578. The position accounts for ﹤0.01% of the portfolio, ranked #752.

ICA Group Wealth Management first reported a position in IDNA in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.35K in Q4 2022. 62 funds tracked by Wall St. Rank hold IDNA as of Q2 2024.

ICA Group Wealth Management held 25 shares of iShares Genomics Immunology and Healthcare ETF worth $578 as of Q2 2024.
ICA Group Wealth Management left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q2 2024.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #752 holding.
ICA Group Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2022 and has held it in 6 quarters since.
ICA Group Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $1.35K in Q4 2022.
62 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.